Significant advancements have been achieved in developing novel cancer immunotherapies in recent years. Targeted immunotherapies such as CAR T-cell therapy and antibody treatments have changed cancer treatment. However, discovering cancer cell surface proteins as immunotherapy targets remains a considerable difficulty. A study group from Lund…[Read more]

Good afternoon everyone!